However, to date, no study has investigated the effects of TSPO ligands on the other hallmark pathology of AD, tauopathy, which is most closely associated with the progression of synaptic and neuronal loss and clinical progression of the disease [2, 13]. This evidence concerns the gene TSPO and Alzheimer disease.